140 related articles for article (PubMed ID: 8088773)
21. The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage.
Shimodaira S; Ishida F; Kobayashi H; Mahbub B; Kawa-Ha K; Kitano K
Br J Haematol; 1995 Jul; 90(3):578-84. PubMed ID: 7646997
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus (EBV)-related lymphoproliferative disorder with subsequent EBV-negative T-cell lymphoma.
Tao Q; Srivastava G; Loke SL; Liang RH; Liu YT; Ho FC
Int J Cancer; 1994 Jul; 58(1):33-9. PubMed ID: 8014013
[TBL] [Abstract][Full Text] [Related]
23. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
24. T gamma/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report.
Kraus MD; Crawford DF; Kaleem Z; Shenoy S; MacArthur CA; Longtine JA
Cancer; 1998 Mar; 82(5):983-92. PubMed ID: 9486591
[TBL] [Abstract][Full Text] [Related]
25. Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome.
Dolezal MV; Kamel OW; van de Rijn M; Cleary ML; Sibley RK; Warnke RA
Am J Clin Pathol; 1995 Feb; 103(2):189-94. PubMed ID: 7856561
[TBL] [Abstract][Full Text] [Related]
26. Detection of clonal Epstein-Barr virus in malignant proliferation of peripheral blood CD3+ CD8+ T cells.
Chan LC; Srivastava G; Pittaluga S; Kwong YL; Liu HW; Yuen HL
Leukemia; 1992 Sep; 6(9):952-6. PubMed ID: 1325583
[TBL] [Abstract][Full Text] [Related]
27. Infiltrations of Epstein-Barr virus-carrying cells in granular lymphocyte-proliferative disorders corresponding to chronic active Epstein-Barr virus infection.
Takechi T; Maeda A; Hisakawa H; Wakiguchi H; Takeuchi T; Sonobe H; Ohtsuki Y
Pediatr Hematol Oncol; 2002; 19(7):459-65. PubMed ID: 12217191
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation.
Gulley ML; Pulitzer DR; Eagan PA; Schneider BG
Hum Pathol; 1996 Jan; 27(1):20-7. PubMed ID: 8543306
[TBL] [Abstract][Full Text] [Related]
29. [Clinical features and laboratory findings of adult Epstein-Barr virus associated T/NK lymphoproliferative disease].
Zhang Q; Zhang HY; Zhang WL; Zhong FL; Feng J; Meng QX; Yin WH; Nie LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):953-7. PubMed ID: 23998592
[TBL] [Abstract][Full Text] [Related]
30. Malignant granular lymphoproliferation after Epstein-Barr virus infection: partial immunologic reconstitution with interleukin-2.
Aronson FR; Dempsey RA; Allegretta M; André-Schwartz J; Poldre PA; Hillyer CD; Parkinson DR; Rudders RA; Schwartz RS; Mier JW
Am J Hematol; 1987 Aug; 25(4):427-39. PubMed ID: 3039837
[TBL] [Abstract][Full Text] [Related]
31. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
Kanno H; Onodera H; Endo M; Maeda F; Chida S; Akasaka T; Sawai T
Hum Pathol; 2005 Feb; 36(2):212-8. PubMed ID: 15754300
[TBL] [Abstract][Full Text] [Related]
32. Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association.
Matano S; Nakamura S; Nakamura S; Annen Y; Hattori N; Kobayashi K; Kyoda K; Sugimoto T
Acta Haematol; 1999; 101(4):206-8. PubMed ID: 10436303
[TBL] [Abstract][Full Text] [Related]
33. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation.
Ebihara Y; Manabe A; Tanaka R; Yoshimasu T; Ishikawa K; Iseki T; Hayakawa J; Maeda M; Asano S; Tsuji K
Bone Marrow Transplant; 2003 Jun; 31(12):1169-71. PubMed ID: 12796798
[TBL] [Abstract][Full Text] [Related]
35. Adult aggressive natural killer cell leukemia.
Zhang H; Meng Q; Yin W; Xu L; Lie L
Am J Med Sci; 2013 Jul; 346(1):56-63. PubMed ID: 23241562
[TBL] [Abstract][Full Text] [Related]
36. Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease.
Ohshima K; Suzumiya J; Kanda M; Kato A; Kikuchi M
Cancer Lett; 1998 Jan; 122(1-2):43-50. PubMed ID: 9464490
[TBL] [Abstract][Full Text] [Related]
37. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus-associated CD3- large granular lymphocyte leukemia presenting with polycranial nerve palsies.
Taniguchi S; Machi M; Ohno Y
Blood; 1996 Jun; 87(11):4914-5. PubMed ID: 8639870
[No Abstract] [Full Text] [Related]
39. Epstein-Barr virus involvement in T-cell malignancy: significance in adult T-cell leukemia.
Ohtsubo H; Arima N; Tei C
Leuk Lymphoma; 1999 May; 33(5-6):451-8. PubMed ID: 10342573
[TBL] [Abstract][Full Text] [Related]
40. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression.
Sugawara Y; Mizugaki Y; Uchida T; Torii T; Imai S; Makuuchi M; Takada K
Virology; 1999 Apr; 256(2):196-202. PubMed ID: 10191184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
